Riskpilot← Back to searchSign inGet full accessSTENOCARE A/S
A/SActiveCVR 39024705Lejrvej 9Manufacture of basic pharmaceutical products · NACE 2110Est. 20174 employeeswww.stenocare.com
Revenue 2024
DKK -18,5M
+199% vs 2023
EBITDA margin
131.2%
-93% vs 2023
Equity ratio
-17.9%
Financial strength
Net profit 2024
DKK -34,5M
-96% vs 2023
| Revenue | DKK -18,5M | +199% |
| EBITDA | DKK -24,2M | -93% |
| Net profit | DKK -34,5M | -96% |
| Total assets | DKK 19,4M | -49% |
| Equity | DKK -3,5M | -113% |
| Employees | 4 | — |
Legal name
STENOCARE A/S
CVR number
39024705
Legal form
Aktieselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
19. oktober 2017
Share capital
DKK 3.472.300
Employees
4 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med en direktør eller af 3 bestyrelsesmedlemmer.
Company purpose
Selskabets formål er at drive virksomhed med forskning, fremstilling, udvikling, forarbejdning, import, salg og distribution af palliative produkter.
Address
Lejrvej 9
Website
www.stenocare.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | -1.125 | 8.784 | 4.145 | -5.756 | -6.410 | -6.185 | -18.474 |
| Staff expenses | -2.466 | -4.367 | -5.836 | -7.235 | -6.805 | -6.378 | -5.756 |
| EBITDA | -3.591 | 4.417 | -3.350 | -12.991 | -13.215 | -12.562 | -24.230 |
| Depreciation & amort. | -1 | -59 | -241 | -1.087 | -3.313 | -3.384 | -8.862 |
| EBIT | -3.592 | 4.358 | -3.591 | -14.078 | -16.528 | -15.947 | -33.092 |
| Net financials | -13 | -2.112 | -1.648 | -181 | -1.360 | -2.876 | -1.505 |
| Profit before tax | -3.605 | 2.246 | -13.719 | -14.260 | -17.888 | -18.823 | -34.597 |
| Tax | -329 | 544 | -1.933 | -1.527 | -1.584 | -1.253 | -108 |
| Net profit | -3.276 | 1.702 | -11.786 | -12.732 | -16.303 | -17.570 | -34.488 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 21.711 | 31.608 | 56.340 | 43.936 | 39.604 | 38.121 | 19.436 |
| Equity | 20.472 | 13.475 | 52.571 | 40.243 | 24.143 | 25.822 | -3.474 |
| Long-term debt | 0 | 0 | 80 | 988 | 4.797 | 936 | 2.461 |
| Short-term debt | 1.238 | 18.134 | 3.690 | 2.390 | 9.612 | 11.255 | 7.229 |
| Total debt | 1.238 | 18.134 | 3.770 | 3.378 | 14.409 | 12.191 | 9.690 |
EBITDA margin
-2423034100.0%
This company
15.8%
Market median
-15335658961% vs market
20182024
Equity ratio
-17.9%
This company
38.2%
Market median
-147% vs market
20182024
Return on equity
-3448840500.0%
This company
18.4%
Market median
-18743698470% vs market
20182024
Net profit margin
-3448840500.0%
This company
8.1%
Market median
-42578277878% vs market
20182024
Asset turnover
-0.95×
This company
1.12×
Market median
-185% vs market
20182024
Debt / equity
6.60×
This company
0.62×
Market median
-965% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-10-19 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK Founder | Founder | 2017 | — | — |
TS Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SC-Founders Holding ApS | Company | 10.0% | 10.0% | 2023 |
HHTM ApS | Company | 10.0% | 10.0% | 2023 |
PRANA HOLDING ApS | Company | 10.0% | 10.0% | 2020 |
| Individual | 15.0% | 15.0% | 2018 | |
| Individual | 5.0% | 5.0% | 2025 | |
MS Kjær Holding ApS | Company | 10.0% | 10.0% | 2020 |
DANCANN PHARMA A/S | Company | 10.0% | 10.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SC-Founders Holding ApS
STENOCARE A/S Board members of STENOCARE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Kjær | Founder | 0 companies |
| Thomas Skovlund Schnegelsberg | Management | 0 companies |
| Rolf Steno Petersen | Board of Directors | 0 companies |
| Ian Abramowitz | Board of Directors | 0 companies |
| Jeppe Bo Petersen | Board of Directors | 0 companies |
| Marianne Wier | Chairman | 0 companies |
| Henrik Elbæk Pedersen | Board of Directors | 0 companies |
| Søren Melsing Frederiksen | Board of Directors | 0 companies |